The novel approach of tirzepatide peptide represents a major development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide905224.blog5.net/94989639/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment